Achieve Life Sciences names Benjamin Halladay CFO, effective Oct. 5

ACHV•2026-10-01

Achieve Life Sciences named Benjamin Halladay chief financial officer effective Oct. 5, 2026, replacing Mark Oki, who will step down that day.

1. CFO transition

Halladay was CFO of Esperion Therapeutics from November 2022 to July 2026. His previous finance experience includes roles at Pfizer and National Oilwell Varco.

Achieve Life Sciences names Benjamin Halladay CFO, effective Oct. 5

1. CFO transition

Related News

AIM ImmunoTech says Phase 2 DURIPANC pancreatic cancer trial advances toward Q1 2027 topline data

BMO, Mastercard roll out embedded commercial virtual card payments in enterprise software across North America

KeyBank names Mike Keane COO of Key Wealth

US jobless claims data

DoubleLine Yield Opportunities Fund declares October distribution of $0.1167 per share